EUVIMEDEUVIMED entdecken
Open Access

Neuroanatomical Subtypes of Schizophrenia Reveal Divergent Atrophy Trajectories and Distinct Associations with Long-Term Clozapine Use

Xiao Chang, Yuchao Jiang, Bochao Danae Lin, Shitong Xiang, Jie Zhang iD, Guusje Collin, Paul Wirsching, Florian Schlagenhauf, Yijie Zhao iD, Hengfen Gong, Yanqun Zheng, Long-Biao Cui iD und 6 weitere

Schizophrenia Bulletin · 27.10.2026 · 52 (6)

DOI: 10.1093/schbul/sbag143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, online erschienen am 30.10.2026. Verfasst von Xiao Chang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Science and Technology for Brain-Inspired Intelligence (ISTBI), Fudan University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Clozapine, Schizophrenia, Antipsychotic Agents, Amygdala. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, 111 Project, Shanghai Municipal Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Schizophrenia is a heterogeneous disorder, and biology-informed stratification may provide insights into individual differences in disease course and treatment response. We hypothesized that neuroimaging-based subtyping could reveal biologically distinct subgroups characterized by divergent brain atrophy trajectories and unique clinical profiles. Study Design We applied the Subtype and Stage Inference framework to baseline structural MRI data from the 6-year longitudinal Genetic Risk and Outcome of Psychosis cohort (n = 467), including patients, unaffected siblings and healthy controls. We characterized subtype-specific longitudinal brain atrophy and medication profiles. Subtype-specific atrophy patterns were correlated with external molecular maps of neurotransmitter density and schizophrenia-related gene expression. Study Results Two distinct neuroanatomical subtypes were identified: subtype 1 (65.5%), characterized by widespread cortical volume loss at baseline, and stable volume decrease over 6-year follow-up. Conversely, subtype 2 (34.5%) showed baseline volume decrease confined in the hippocampus and amygdala, but accelerated volume loss over follow-up. Clinically, subtype 1 patients had a significantly higher prevalence of clozapine use than subtype 2 (36% vs. 17%; chi2 = 5.62, P = 0.02), and brain atrophy of subtype 1 mirrored patterns observed in clozapine users. The two subtypes showed divergent spatial associations with neurotransmitter systems and risk-gene expression profiles. Conclusions We identified two neuroanatomical subtypes of schizophrenia showing divergent brain atrophy over 6-years. The subtypes may represent biologically distinct forms of schizophrenia, as they show different medication profiles and associations with molecular signatures. Our results provide a candidate framework for parsing disease heterogeneity and may offer insights for future stratified treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineSchizophreniaAntipsychotic AgentsAmygdalaHippocampusCerebral CortexHumansAtrophyFemaleMaleMagnetic Resonance ImagingLongitudinal StudiesAdultYoung AdultGene Expression

Stichwörter der Autor:innen

clozapinelongitudinalschizophreniasiblingsubtype

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • Institute of Science and Technology for Brain-Inspired Intelligence (ISTBI), Fudan University, Shanghai 200433, China.
  • Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Fudan University, Ministry of Education, Shanghai 200433, China.
  • Centre for Population Neuroscience and Stratified Medicine (PONS), ISTBI, Fudan University, Shanghai 200433, China.
  • MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200433, China.
  • School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China.
  • Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht 6229 HX, The Netherlands.

ORCID-Profile: Jie Zhang, Yijie Zhao, Long-Biao Cui, Tianye Jia

Förderung

  • National Key R&D Program of China
  • 111 Project
  • Shanghai Municipal Science and Technology Major Project
  • Shanghai Center for Brain Science and Brain-Inspired Technology
  • National Natural Science Foundation of China
  • Shanghai Sailing Program
  • Geestkracht programme of the Dutch Health Research Council

Zitieren

APA

Chang, X., Jiang, Y., Lin, B. D., Xiang, S., Zhang, J., Collin, G., Wirsching, P., Schlagenhauf, F., Zhao, Y., Gong, H., Zheng, Y., Cui, L. B., Wang, J., Jia, T., Heinz, A., Luykx, J. J., Feng, J., & Zhangjiang International Brain Biobank (ZIB) Consortium (2026). Neuroanatomical Subtypes of Schizophrenia Reveal Divergent Atrophy Trajectories and Distinct Associations with Long-Term Clozapine Use. Schizophrenia Bulletin, 52(6). https://doi.org/10.1093/schbul/sbag143

Vancouver

Chang X, Jiang Y, Lin BD, Xiang S, Zhang J, Collin G, et al. Neuroanatomical Subtypes of Schizophrenia Reveal Divergent Atrophy Trajectories and Distinct Associations with Long-Term Clozapine Use. Schizophrenia Bulletin. 2026;52(6). doi:10.1093/schbul/sbag143

BibTeX
@article{Chang2026,
  author = {Chang, Xiao and Jiang, Yuchao and Lin, Bochao Danae and Xiang, Shitong and Zhang, Jie and Collin, Guusje and Wirsching, Paul and Schlagenhauf, Florian and Zhao, Yijie and Gong, Hengfen and Zheng, Yanqun and Cui, Long-Biao and Wang, Jijun and Jia, Tianye and Heinz, Andreas and Luykx, Jurjen J and Feng, Jianfeng and Zhangjiang International Brain Biobank (ZIB) Consortium, Zhangjiang International Brain Biobank (ZIB) Consortium},
  title = {Neuroanatomical Subtypes of Schizophrenia Reveal Divergent Atrophy Trajectories and Distinct Associations with Long-Term Clozapine Use},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  volume = {52},
  number = {6},
  doi = {10.1093/schbul/sbag143}
}
Kostenlos starten →